Select Medical Holdings Corporation’s recently made public that its Director Khanuja Parvinderjit S. acquired Company’s shares for reported $0.32 million on May 05 ’25. In the deal valued at $15.02 per share,21,000 shares were bought. As a result of this transaction, Khanuja Parvinderjit S. now holds 65,089 shares worth roughly $1.0 million.
Then, CHERNOW DAVID S sold 225,000 shares, generating $4,050,000 in total proceeds. Upon selling the shares at $18.00, the CEO now owns 714,516 shares.
Before that, CHERNOW DAVID S bought 225,000 shares. Select Medical Holdings Corporation shares valued at $4,050,000 were divested by the Officer at a price of $18.00 per share.
Mizuho initiated its Select Medical Holdings Corporation [SEM] rating to an Outperform in a research note published on April 16, 2025; the price target was $25. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who increased its forecast for the stock in late February from “a Hold” to “a Buy”. The Benchmark Company also remained covering SEM and has decreased its forecast on November 25, 2024 with a “Hold” recommendation from previously “Buy” rating.
Price Performance Review of SEM
On Friday, Select Medical Holdings Corporation [NYSE:SEM] saw its stock jump 0.79% to $15.35. Over the last five days, the stock has gained 2.88%. Select Medical Holdings Corporation shares have fallen nearly -18.57% since the year began. Nevertheless, the stocks have fallen -16.37% over the past one year. While a 52-week high of $22.07 was reached on 01/28/25, a 52-week low of $14.03 was recorded on 05/02/25. SMA at 50 days reached $16.38, while 200 days put it at $25.03.
Levels Of Support And Resistance For SEM Stock
The 24-hour chart illustrates a support level at 15.17, which if violated will result in even more drops to 14.99. On the upside, there is a resistance level at 15.47. A further resistance level may holdings at 15.59. The Relative Strength Index (RSI) on the 14-day chart is 45.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.15%. Stochastics %K at 24.48% indicates the stock is a holding.
The most recent change occurred on May 13, 2021 when The Benchmark Company resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $44.
